Loading…
ENDATA>
ENDATAProduction of oral APIs at Sandoz's Les Franqueses site will be phased out by 2024, with production transferred to Palafolls.
Sandoz will invest $61 million into its Palafolls site in Spain to increase penicillin production capacity.
Sandoz, a division of Novartis, will invest more than $122 million to add new technology at its Kundl, Austria plant to make oral amoxicillin API, and $61 million into its Palafolls site in Spain to increase penicillin production capacity. Production at the Les Franqueses site will be phased out by 2024.
| Site | Largest | Latest |
|---|---|---|
| Kundl, Austria | $122.0M | 2021-05-20 |
| Les Franqueses, Spain | 2021-05-20 | |
| Palafolls, Spain | $61.0M | 2021-05-20 |